Acquired Metabolic Disorders Flashcards
1
Q
The liver: functions, and what happens when fails
A
- can function on 20%
- filters blood 20x per hour
- handles protein turnover and is principle site of urea synthesis which is excreted in urine (handles toxic NH3)- converts glutamine (from muscle) to urea, also converts ammonia produce by gut bacteria into urea
- jaundice is a sign of liver failure as would normally push bilirubin out in bile but due to failure it is stuck in skin
- if liver fails can get hepatic encephalopathy
2
Q
Hepatic encephalopathy: causes, symptoms, severity assessment, types
A
- cause: liver failure causes nitrogen build up which can cerebral oedema and may cause neuropsychiatric syndrome and increased inter-cranial pressure
- symptoms/ severity (West Haven Criteria): 0 (covert HE), 1 (confusion), 2 (drowsiness), 3 (somnolence), 4 (coma)
- can causes brain to collapse in on self
- type A: caused by acute liver failure. Leads to astrocytic swelling and increased intercranial pressure
- Type C: cirrhosis (chronic disease). Causes alzheimers type II astrocytosis and normal ICP
3
Q
Cytotoxicity in HE: what causes swelling?
A
- normally have myoinositol and taurine controlling osmolarity of astrocytes
- in acute disease have increased influx of glutamine/ NH3 rapidly and cannot control osmolality and therefore causes swelling
4
Q
Adverse effects of ammonia in the body
A
- causes neuroinhibiton and down regulation of neuroexcitation
- inhibits Cl- channels
- derangement of the blood brain barrier
5
Q
Precipitants of hepatic enencephalopathy
A
- excess protein (although a low protein diet has shown no beneficial effect for HE therefore normal guidelines apply)
- alcohol
- hepatic cell carcinoma
- infection
- GI bleed
- sedative/ hypnotics
- diuretics
6
Q
Metabolic syndrome symptoms and diagnostic criteria (WHO and IDF)
A
- IDF requires central obesity + 2 other abnormalities
- WHO requires microalbuminema in addition (albumin/ creatinine ratio of >30mg/g creatinine)
- obesity: IDF (central obesity, 80cm waist women and 94cm men), WHO (waist/hip ratio >0.9 men and >0.85 women)
- abnormal fasting glucose: IDF (>5.6mmol/L or previous T2DM), WHO (presence of diabetes, insulin resistance)
- hypertension: IDF (BP 130/85 mmHg), WHO (BP >140/90 mmHg)
- dyslipidemia: IDF (TG of 1.7mmol/L, HDL <40mg/dL men and <50mg/dL women), WHO (TG 1.7 mmol/L, HDL <35 mg/dL men and <39 mg/dL women)
- microalbuminema (just WHO)
7
Q
Risk factors and diseases related to MetS
A
- risk factors: proinflammatory states, prothrombotic states
- diseases at risk of: T2DM, hypertension, PCOS, NAFLD, sleep apnea, CVD (stroke, MI), cancer (breast, prostate, colorectal, liver)
8
Q
Causes of hyperglycaemia in T2DM
A
- partial defect of insulin secretion: lipid droplets accumulate in pancreas and inhibit b cell ability to secrete insulin, and these cells undergo apoptosis. Due to lack of insulin secretion, still lots of endogeneous glucose production in liver (gluconeogenesis). Glycation of proteins on b cells may also reduce function
- resistance to action of insulin: downregulation in use of glucose oxidation in periphery due to circulating FFA (excess released from AT), causes reduced uptake of glucose from muscle
9
Q
Link between MetS insulin resistance and atherosclerosis
A
- increased TG decreased HDL cholesterol and forms dense LDL contributing to plaque formation
- increased BP and endothelial dysfunction (response to injury hypothesis for atherosclerosis)
10
Q
Complications of T2DM
A
- retinopathy
- abnormal ECG
- absent foot pulses/ ischemic feet
- impaired reflexes
- myocardial infarction
- stroke
11
Q
Diagnosis of insulin resistance using oral glucose tolerance test
A
- in a fasted state a glucose load (75g oral) given and blood sampled every 2-4 hours)
- a normal person will have a small transient rise in BG
- if insulin resistant BG curve may look normal
- impaired glucose tolerance: basal glucose high and continues to rise after load
- diabetes mellitus: very high BG and linear increase in BG after load
12
Q
Consequences of insulin resistance in the muscle, liver and pancreas
A
- muscle: increase in intramyocellular lipids, decreased glucose uptake
- liver: increased TG synthesis, increased gluconeogenesis (contributing to high BG)
- pancreas: lipid droplets accumulate and make beta cells apoptotic and decrease circulating insulin
13
Q
Treatment options for insulin resistance
A
- diet and exercise: to reduce fat mass, improve lean body mass and improve insulin sensitivity
- insulin releasing drugs: to stimulate pancreas to release more insulin, and so plasma glucose is taken up by cells
- hepatic insulin sensitisers: works selectively on lover inhibiting glycogenolysis and gluconeogenesis, to reduce hepatic BG output